Block Grant R43CA134031

This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...

The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...

The National Science Foundation awarded a $266,000 Project Grant to Columbia University under the NSF Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a wearable noninvasive brain imaging device using near-infrared light-based time-domain diffuse optical tomography. The device aims to improve clinical outcomes in neurology by enabling measurement of deep brain blood flow, which is difficult to measure with current technologies. The grant will support...

Federal Project Grant Summary O2M Technologies LLC received a $1.164M Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded September 19, 2025, with completion scheduled for August 31, 2027. The grant funds the development of advanced pulse Electron Paramagnetic Resonance Imaging (PEPRI) technology to enable rapid and precise oxygen pressure (pO2) measurements in tissues. Specifically, the project delivers a novel Single...

This $276,000 National Science Foundation award through the Technology, Innovation, and Partnerships program will support the development of a cognitive dashboard software platform to aid neurosurgical clinical decision-making. Mindtrace Technologies, Inc. will deliver a turn-key software solution that enables neurosurgical teams to map individual patient brain functions, assess and track measures of mental performance throughout care, and integrate with existing medical imaging and data...

Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Leland Stanford Junior University a Project Grant of $499,516 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective February 1, 2026, through January 31, 2031. This five-year research initiative aims to develop a novel imaging strategy to optimize brain tumor immunotherapy by creating a first-in-class positron emission...

Federal Grant Award Summary Cordance Medical Inc. received a $999,125 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) effective September 11, 2025, with completion targeted for August 31, 2027. The company is developing and validating the NeuroAccess system, a focused ultrasound device designed to temporarily and safely open the blood-brain barrier (BBB) to enable a novel liquid biopsy technique called sonobiopsy for...

Mindtrace Technologies, Inc. received a $1.2M Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective May 15, 2025, through April 30, 2027. The company is developing a novel cognitive dashboard software platform designed to support clinical decision-making in neurosurgery by integrating multiple data sources including behavioral assessments, functional brain mapping protocols, and...

This $256,000 National Science Foundation Project Grant under the Engineering (47.041) program will support the development of an artificial intelligence-based system for analyzing multiparametric magnetic resonance imaging (MRI) scans to detect prostate lesions. The awardee, Taurus Diagnostics, Inc., will create a novel prostate cancer diagnostic platform leveraging artificial intelligence image analysis for high sensitivity and specificity. Key objectives include developing methods to...

Federal Grant Award Summary Evanesc Therapeutics, Inc. received a $349,908 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded September 1, 2025, with completion targeted for August 31, 2026. The company is developing and validating EVAPERMEA, a non-invasive medical device designed to reversibly permeabilize the blood-brain barrier...